Using glucocorticoids to relieve acute osteoarthritis pain in the emergency department
Official title: Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
Run by WellSpan Health · NCT06603662 · Data updated 2026-11-12
This study is testing if adding glucocorticoids to regular pain medications can help adults with sudden osteoarthritis pain feel better in the emergency department.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 192 (estimated) |
| Sponsor | WellSpan Health Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (York, Pennsylvania) |
| Status | Recruiting |
| Started | February 24, 2025 |
| Main results expected | October 2027 |
| Study ends | December 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT06603662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with acute joint pain in the knee, hip, or shoulder due to osteoarthritis.
✕Probably not a fit
Patients with recent trauma to the affected joint or those with other inflammatory joint conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to compare the effectiveness of oral glucocorticoids combined with standard pain medications against standard pain medications alone in adults experiencing acute joint pain due to osteoarthritis. The study will assess both the pain relief provided by the glucocorticoids and their safety and tolerability for short-term use. Participants will be randomly assigned to receive either the glucocorticoids or a placebo, with pain scores evaluated three days after treatment initiation. The goal is to determine if glucocorticoids can enhance pain management in emergency settings for osteoarthritis patients.
Why it matters
Potential benefit: If successful, this approach could provide more effective pain relief for patients suffering from acute osteoarthritis pain.
How similar studies have gone: Previous studies have shown positive outcomes with glucocorticoid injections for osteoarthritis pain, but this oral approach is less commonly tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Acute monoarticular arthritic joint pain affecting native knee, hip, or shoulder presumed to be related to osteoarthritis * Acute pain above baseline starting less than 72 hour prior to ED visit * Planned discharge from the ED * History of osteoarthritis of the affected joint based on radiography performed at index visit or prior available imaging Exclusion Criteria: * Trauma to the affected joint within 30 days * Injection of affected joint within 60 days * Prior arthroplasty of the affected joint * History of coronary artery disease, severe gastrointestinal bleeding, gastric/peptic ulcer disease, chronic kidney disease with GFR less than 30, or platelet disorders (including von Willebrand disease, hemophilia, severe thrombocytopenia with platelets less than 50 k/mcL) * Joint pain suspected to be related to rheumatoid arthritis, gout, septic arthritis, or other non-osteoarthritis autoimmune/inflammatory/infectious arthritis * Chronic/baseline use of glucocorticoids (greater than 5 mg daily prednisone or equivalent within previous 7 days) or NSAIDs (daily use for more than 2 days prior to presentation) * Daily prescription opioid use or active opioid use disorder * Illicit drug use * Known allergy/intolerance to ibuprofen/NSAIDs, prednisone, dexamethasone, or other medication precluding ability to participate in one or more study arms * Other contraindications to ibuprofen/NSAIDs or glucocorticoids * Planned hospitalization from the ED * Pregnancy * Incarceration * Inability to provide informed consent * Other conditions that would preclude compliance with the study protocol and medication dosing
Where it's running
-
WellSpan York Hospital
York, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Brent Becker, MD — WellSpan Health
- Study coordinator: Kristen Oliff Oliff
- Email: koliff@wellspan.org
- Phone: 717-812-5075
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Herbal combination (Boswellia, turmeric, grape extract) for hip or knee osteoarthritis
This study will test whether a daily herbal supplement containing Boswellia serrata, turmeric (curcumin), and grape extract (Vitis vinifera) reduces pain and improves function in adults with hip or knee osteoarthritis.
-
Platelet-rich plasma injections for joint and tendon problems
This project will test whether platelet-rich plasma (PRP) injections help people with osteoarthritis and other musculoskeletal conditions reduce pain and improve function over one year.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Virtual reality versus traditional relaxation to ease pain and improve sleep after hip or knee replacement
This will test whether relaxation using virtual reality or traditional relaxation works better to reduce pain and improve sleep in adults after hip or knee replacement.
-
Choose to Move Replacement Ready for people waiting for hip or knee replacement
This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.
-
Acupuncture treatment for knee osteoarthritis
This study is testing if acupuncture can help relieve knee pain and improve movement in people with knee osteoarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.